Additionally, to verify that IL‐22 plays an essential role in relieving the inflammatory response of colitis mice, IBD mice received intravenous injection of recombinant IL‐22 protein (rIL‐22) and anti‐IL‐22 antibody that neutralizes IL‐22 by blocking its expression (IL‐22 B). The gene discussed is IL22; the disease is colitis.